Invirase (saquinavir Mesylate) - Need For Electrocardiogram Monitoring In Patients - For The Public

INVIRASE Recall Summary INVIRASE (saquinavir mesylate), an HIV medication, requires electrocardiogram monitoring in patients because the drug can cause changes in heart rhythm. This notification applies to all patients in Canada taking this medication. Healthcare providers should monitor patients' heart activity while they are on this drug.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2010-11-02

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/e2269641-6c91-4a21-a782-aa3cb8171ea7